.Bristol Myers Squibb is actually axing an additional large wager from the Caforio age, ending a pac...
.After having a look at phase 1 data, Nuvation Biography has decided to halt work on its own one-tim...
.Zevra Therapeutics' unusual condition medication seems to become on the road to authorization this ...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has gone a $230 thousand...
.After greater than two decades of work with neurodegenerative diseases, Swiss biotech AC Immune sys...
.GSK has actually ditched a period 2 human papillomavirus (HPV) vaccine from its pipe after determin...
.OS Therapies will provide on the NYSE American supply swap today via a $6.4 million IPO that the bi...
.ALX Oncology's period 2 stomach cancer response fee has weakened. After seeing its CD47 blocker eff...
.Another of Ionis Pharmaceuticals' key midphase readouts has fallen short of requirements, cuing the...
.While Biogen's pharma peers are actually searching for late-stage properties with little bit of thr...